Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ionis Pharmaceuticals, Inc.(IONS) | 250,000 | 500,000 | +250,000 | $7.54M | $19.75M | 12.84% | +$12.21M |
| Rezolute, Inc.(RZLT) | 833,042 | 3,033,462 | +2,200,420 | $2.42M | $13.53M | 8.80% | +$11.11M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 1,811,996 | 2,000,000 | +188,004 | $6.41M | $12.82M | 8.34% | +$6.41M |
| Legend Biotech CorporationADS(LEGN) | 138,240 | 350,000 | +211,760 | $4.69M | $12.42M | 8.08% | +$7.73M |
| ABIVAX Société AnonymeADS(ABVX) | 1,638,111 | 1,291,617 | -346,494 | $10.24M | $9.88M | 6.42% | -$357.3K |
| Neurogene Inc.(NGNE) | 470,964 | 485,859 | +14,895 | $5.51M | $7.26M | 4.72% | +$1.75M |
| Akebia Therapeutics, Inc.(AKBA) | 4,973,840 | 1,985,915 | -2,987,925 | $9.55M | $7.23M | 4.70% | -$2.32M |
| Evolus, Inc.(EOLS) | 944,743 | 720,118 | -224,625 | $11.37M | $6.63M | 4.31% | -$4.73M |
| Arcellx Inc COMMON STOCK | 45,000 | 100,000 | +55,000 | $2.95M | $6.58M | 4.28% | +$3.63M |
| Xenon Pharmaceuticals Inc.(XENE) | 245,272 | 200,000 | -45,272 | $8.23M | $6.26M | 4.07% | -$1.97M |
| Akero Therapeutics Inc | 0 | 103,848 | +103,848 | $0 | $5.54M | 3.60% | +$5.54M |
| Jade Biosciences Inc | 0 | 498,054 | +498,054 | $0 | $4.98M | 3.24% | +$4.98M |
| Cytokinetics, Incorporated(CYTK) | 370,000 | 150,000 | -220,000 | $14.87M | $4.96M | 3.22% | -$9.91M |
| Immunovant, Inc.(IMVT) | 375,000 | 262,176 | -112,824 | $6.41M | $4.19M | 2.73% | -$2.21M |
| Unicycive Therapeutics, Inc.(UNCY) | 0 | 796,558 | +796,558 | $0 | $3.80M | 2.47% | +$3.80M |
| Kalvista Pharmaceuticals Inc | 1,014,367 | 323,170 | -691,197 | $11.71M | $3.65M | 2.38% | -$8.05M |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 1,500,000 | +1,500,000 | $0 | $3.46M | 2.25% | +$3.46M |
| DBV Technologies S.A.ADS(DBVT) | 0 | 374,679 | +374,679 | $0 | $3.43M | 2.23% | +$3.43M |
| Zura Bio LimitedCL A(ZURA) | 3,170,194 | 3,170,194 | 0 | $4.09M | $3.33M | 2.16% | -$760.8K |
| Upstream Bio, Inc.(UPB) | 300,000 | 300,000 | 0 | $1.84M | $3.29M | 2.14% | +$1.46M |
| Context Therapeutics Inc.(CNTX) | 4,683,711 | 4,683,711 | 0 | $2.87M | $3.07M | 2.00% | +$202.3K |
| Centessa Pharmaceuticals PlcADS | 149,702 | 225,000 | +75,298 | $2.15M | $2.96M | 1.92% | +$803.8K |
| Scholar Rock Holding Corporation(SRRK) | 0 | 61,607 | +61,607 | $0 | $2.18M | 1.42% | +$2.18M |
| Promis Neurosciences Inc | 2,645,128 | 2,645,128 | 0 | $1.84M | $1.28M | 0.83% | -$560.0K |
| Pliant Therapeutics, Inc.(PLRX) | 850,000 | 850,000 | 0 | $1.15M | $986.0K | 0.64% | -$161.5K |
| Helix Acquisition Corp IiCL A | 373,833 | 29,381 | -344,452 | $4.22M | $312.0K | 0.20% | -$3.91M |
| Ascendis Pharma A/SADR(ASND) | 50,000 | 0 | -50,000 | $7.79M | $0 | — | -$7.79M |
| Autolus Therapeutics plcADS(AUTL) | 2,728,910 | 0 | -2,728,910 | $4.23M | $0 | — | -$4.23M |
| Beam Therapeutics Inc.(BEAM) | 175,562 | 0 | -175,562 | $3.43M | $0 | — | -$3.43M |
| Dianthus Therapeutics, Inc.(DNTH) | 275,000 | 0 | -275,000 | $4.99M | $0 | — | -$4.99M |
| Dynavax Technologies Corp | 595,879 | 0 | -595,879 | $7.73M | $0 | — | -$7.73M |
| Mereo BioPharma Group plcADS(MREO) | 1,275,000 | 0 | -1,275,000 | $2.87M | $0 | — | -$2.87M |
| Merus N V | 237,156 | 0 | -237,156 | $9.98M | $0 | — | -$9.98M |
| Unicycive Therapeutics Inc | 10,980,000 | 0 | -10,980,000 | $6.31M | $0 | — | -$6.31M |
| Vaxcyte, Inc.(PCVX) | 115,517 | 0 | -115,517 | $4.36M | $0 | — | -$4.36M |
| Viridian Therapeutics, Inc.(VRDN) | 750,000 | 0 | -750,000 | $10.11M | $0 | — | -$10.11M |
| Voyager Therapeutics, Inc.(VYGR) | 626,275 | 0 | -626,275 | $2.12M | $0 | — | -$2.12M |